News stories about NanoString Technologies (NASDAQ:NSTG) have been trending somewhat positive this week, Accern reports. Accern scores the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. NanoString Technologies earned a news impact score of 0.14 on Accern’s scale. Accern also gave headlines about the biotechnology company an impact score of 46.9993904697792 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

NanoString Technologies (NSTG) traded up $0.25 during midday trading on Thursday, hitting $7.80. 164,000 shares of the stock were exchanged, compared to its average volume of 204,230. NanoString Technologies has a twelve month low of $7.03 and a twelve month high of $23.31. The company has a debt-to-equity ratio of 1.08, a quick ratio of 2.89 and a current ratio of 3.35.

NanoString Technologies (NASDAQ:NSTG) last posted its earnings results on Thursday, November 2nd. The biotechnology company reported ($0.45) EPS for the quarter, topping analysts’ consensus estimates of ($0.56) by $0.11. NanoString Technologies had a negative net margin of 44.24% and a negative return on equity of 174.55%. The business had revenue of $27.02 million for the quarter, compared to analysts’ expectations of $26.27 million. During the same period in the previous year, the company posted ($0.51) earnings per share. The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. equities research analysts anticipate that NanoString Technologies will post -1.77 earnings per share for the current year.

A number of research analysts have recently commented on the stock. Cowen reissued a “buy” rating and set a $20.00 target price on shares of NanoString Technologies in a research report on Thursday, September 28th. Robert W. Baird reissued a “buy” rating and set a $14.00 target price on shares of NanoString Technologies in a research report on Tuesday, October 24th. Zacks Investment Research raised shares of NanoString Technologies from a “sell” rating to a “hold” rating in a research report on Wednesday, November 8th. Finally, Janney Montgomery Scott cut shares of NanoString Technologies from a “buy” rating to a “neutral” rating in a research report on Thursday, October 12th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $17.25.

COPYRIGHT VIOLATION NOTICE: “NanoString Technologies (NSTG) Getting Somewhat Positive Press Coverage, Report Finds” was first published by Watch List News and is the property of of Watch List News. If you are accessing this story on another site, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this story can be read at

About NanoString Technologies

NanoString Technologies, Inc develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample.

Insider Buying and Selling by Quarter for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with Analyst Ratings Network's FREE daily email newsletter.